Wells's purchase set off a market reaction
Wells's purchase set off a market reaction: director David Wells (a former Netflix CFO) bought $1.17 million of stock on the open market, lifting the shares by about 7% to $25.37. It was the first insider purchase since the Q1 results, and the market read it as a signal of management's confidence in the current valuation.
Read more
FINRA short-interest data (settlement date 15 May): 63,372,020 shares sold short (30.72%), broadly flat on the 63,160,154 (30.66%) at the previous reading on 30 Apr. After falling steadily from the March high of about 71 million shares, short interest has stabilised at around 63 million shares. The technicals show an early reversal signal: the 20-day moving average has crossed above the 50-day (a rebuild signal). The RSI is 45.59, in neutral territory. Key resistance is at $30.50, support is at $21.50, and the 200-day moving average at $34.80 is still 27% above the price. Valuation remains at historic lows: forward P/S is only 1.7x, below the two-year median of 3x and below the healthcare sector average of 2.1x. The three-month rebound of 51.9% has yet to repair the 53.1% fall over the past year.
Key data
- Insider buying
- Amount (USD)
1170000
- Buyer
David Wells (former Netflix CFO)
- Price
25.37
- 1-year price change
-53.1%
- 3-month price change
+51.9%
- Short interest
- % of float
30.72
- Settlement date
2026-05-15
- Shares
63372020
- Stock
HIMS
- Technicals
- RSI
45.59
- 200-day MA
34.8
- MA signal
20-day moving average crosses above 50-day
- Resistance
30.5
- Support
21.5
- Valuation
- 2-year median P/S
3.0
- Forward P/S
1.7
- Sector average P/S
2.1
A brief is a lead for our research, not a verified conclusion or advice.